Long-term follow-up of patients treated with laser balloon for atrial fibrillation: A high volume center experience with the first- and second-generation laser balloon

IF 1.7 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of Arrhythmia Pub Date : 2024-06-14 DOI:10.1002/joa3.13088
Lukas Urbanek MD, Stefano Bordignon MD, Shota Tohoku MD, Jun Hirokami MD, Takahiko Nagase MD, Shaojie Chen MD, David Schaack MD, K. R. Julian Chun MD, Boris Schmidt MD
{"title":"Long-term follow-up of patients treated with laser balloon for atrial fibrillation: A high volume center experience with the first- and second-generation laser balloon","authors":"Lukas Urbanek MD,&nbsp;Stefano Bordignon MD,&nbsp;Shota Tohoku MD,&nbsp;Jun Hirokami MD,&nbsp;Takahiko Nagase MD,&nbsp;Shaojie Chen MD,&nbsp;David Schaack MD,&nbsp;K. R. Julian Chun MD,&nbsp;Boris Schmidt MD","doi":"10.1002/joa3.13088","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Laser balloon (LB) pulmonary vein isolation (PVI) is an established ablation technique for atrial fibrillation (AF). We report long-term follow-up and procedural data of LB-PVI and we compare the first and second LB generation.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Patients undergoing LB ablation with first- (LB1) or second-generation LB (LB2) for AF were retrospectively enrolled and divided into two groups. Procedural endpoint was complete PVI. Clinical success was defined as no recurrence of AF/atrial tachycardia after a 90 days blanking period.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>538 patients were included (age 66 ± 10 years, 58% paroxysmal AF), 427 in LB1 and 111 in LB2. 2079 PVs were targeted and 2073 (99.7%) were successfully isolated; 2027 (97.5%) using solely the LB. Additional touch-up ablation was limited (46 PVs; 2.2%) with no difference between the groups. Procedural (LB1: 120 ± 33 minutes vs. LB2: 99 ± 22 min; <i>p</i> &lt; .001) and fluoroscopy time (LB1: 11.2 ± 5 min vs. LB2: 8.5 ± 3 min; <i>p</i> &lt; .001) were shorter with LB2. The complication rate was 8.9% (LB1: 10.1% vs. LB2: 4.5%; <i>p</i> = .067) with most complications resulting from the access site (21/48). Overall freedom from AF after 1-year was 73.7% (paroxysmal AF: 76.9%; persistent AF: 69.3%; <i>p</i> &lt; .001) with no difference between the groups (LB1: 73.4% vs. LB2: 74.7%; <i>p</i> = .491).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>LB showed a high efficacy and acceptable safety, with numerically lower complication rates with the second-generation LB. Procedure and fluoroscopy times were shorter with LB2. Overall, 73.7% of patients were free from AF at 1-year, with comparable results among both generations.</p>\n </section>\n </div>","PeriodicalId":15174,"journal":{"name":"Journal of Arrhythmia","volume":"40 4","pages":"839-848"},"PeriodicalIF":1.7000,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/joa3.13088","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Arrhythmia","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/joa3.13088","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Laser balloon (LB) pulmonary vein isolation (PVI) is an established ablation technique for atrial fibrillation (AF). We report long-term follow-up and procedural data of LB-PVI and we compare the first and second LB generation.

Methods

Patients undergoing LB ablation with first- (LB1) or second-generation LB (LB2) for AF were retrospectively enrolled and divided into two groups. Procedural endpoint was complete PVI. Clinical success was defined as no recurrence of AF/atrial tachycardia after a 90 days blanking period.

Results

538 patients were included (age 66 ± 10 years, 58% paroxysmal AF), 427 in LB1 and 111 in LB2. 2079 PVs were targeted and 2073 (99.7%) were successfully isolated; 2027 (97.5%) using solely the LB. Additional touch-up ablation was limited (46 PVs; 2.2%) with no difference between the groups. Procedural (LB1: 120 ± 33 minutes vs. LB2: 99 ± 22 min; p < .001) and fluoroscopy time (LB1: 11.2 ± 5 min vs. LB2: 8.5 ± 3 min; p < .001) were shorter with LB2. The complication rate was 8.9% (LB1: 10.1% vs. LB2: 4.5%; p = .067) with most complications resulting from the access site (21/48). Overall freedom from AF after 1-year was 73.7% (paroxysmal AF: 76.9%; persistent AF: 69.3%; p < .001) with no difference between the groups (LB1: 73.4% vs. LB2: 74.7%; p = .491).

Conclusion

LB showed a high efficacy and acceptable safety, with numerically lower complication rates with the second-generation LB. Procedure and fluoroscopy times were shorter with LB2. Overall, 73.7% of patients were free from AF at 1-year, with comparable results among both generations.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
使用激光球囊治疗心房颤动患者的长期随访:大容量中心使用第一代和第二代激光球囊的经验
激光球囊(LB)肺静脉隔离术(PVI)是治疗心房颤动(AF)的成熟消融技术。我们报告了 LB-PVI 的长期随访和手术数据,并对第一代和第二代 LB 进行了比较。我们回顾性地纳入了接受第一代(LB1)或第二代(LB2)LB 消融术的房颤患者,并将其分为两组。手术终点为完全PVI。共纳入 538 名患者(年龄 66 ± 10 岁,58% 为阵发性房颤),其中 427 名患者接受了 LB1,111 名患者接受了 LB2。2079 个 PV 被锁定,2073 个(99.7%)成功隔离;2027 个(97.5%)仅使用 LB。额外的修补消融有限(46 个 PV;2.2%),组间无差异。LB2 的手术时间(LB1:120 ± 33 分钟 vs. LB2:99 ± 22 分钟;p < .001)和透视时间(LB1:11.2 ± 5 分钟 vs. LB2:8.5 ± 3 分钟;p < .001)更短。并发症发生率为 8.9%(LB1:10.1% vs. LB2:4.5%;p = .067),其中大部分并发症来自入路部位(21/48)。1年后房颤的总体治愈率为73.7%(阵发性房颤:76.9%;持续性房颤:69.3%;p < .001),组间无差异(LB1:73.4% vs. LB2:74.7%;p = .491)。LB显示出很高的疗效和可接受的安全性,第二代LB的并发症发生率在数字上更低。LB2 的手术和透视时间更短。总体而言,73.7%的患者在1年后摆脱了房颤,两代产品的效果相当。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Arrhythmia
Journal of Arrhythmia CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.90
自引率
10.00%
发文量
127
审稿时长
45 weeks
期刊最新文献
Association Between Bradyarrhythmia Requiring Permanent Pacemaker Implantation and Epicardial Adipose Tissue in Elderly Patients. Early Versus Later Anticoagulation for Acute Ischemic Stroke in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis Comment on “Utility of a Novel 12-Lead ECG Criterion for Localizing Manifest Right-Sided Accessory Pathways: A Derivation Study” Atrial Fibrillation Ablation in Patients With Heart Failure and Preserved Ejection Fraction: Faux Pas, Great Absences, and New Hopes A New Mechanistic Insight Into Macro-Reentrant Atrial Tachycardia in a Patient With Modified Fontan Circulation
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1